254 related articles for article (PubMed ID: 26546117)
1. Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.
Chlebowski RT; Anderson GL; Aragaki AK; Prentice R
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26546117
[TBL] [Abstract][Full Text] [Related]
2. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
3. Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women.
Chlebowski RT; Aragaki AK; Anderson GL; Prentice RL
Cancer; 2020 Jul; 126(13):2956-2964. PubMed ID: 32212335
[TBL] [Abstract][Full Text] [Related]
4. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.
Chlebowski RT; Anderson GL; Manson JE; Schwartz AG; Wakelee H; Gass M; Rodabough RJ; Johnson KC; Wactawski-Wende J; Kotchen JM; Ockene JK; O'Sullivan MJ; Hubbell FA; Chien JW; Chen C; Stefanick ML
J Natl Cancer Inst; 2010 Sep; 102(18):1413-21. PubMed ID: 20709992
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women.
Rosenberg L; Bethea TN; Viscidi E; Hong CC; Troester MA; Bandera EV; Haiman CA; Kolonel LN; Olshan AF; Ambrosone CB; Palmer JR
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26613937
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT; Rohan TE; Manson JE; Aragaki AK; Kaunitz A; Stefanick ML; Simon MS; Johnson KC; Wactawski-Wende J; O'Sullivan MJ; Adams-Campbell LL; Nassir R; Lessin LS; Prentice RL
JAMA Oncol; 2015 Jun; 1(3):296-305. PubMed ID: 26181174
[TBL] [Abstract][Full Text] [Related]
8. Changing concepts: Menopausal hormone therapy and breast cancer.
Chlebowski RT; Anderson GL
J Natl Cancer Inst; 2012 Apr; 104(7):517-27. PubMed ID: 22427684
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.
Hou N; Hong S; Wang W; Olopade OI; Dignam JJ; Huo D
J Natl Cancer Inst; 2013 Sep; 105(18):1365-72. PubMed ID: 24003037
[TBL] [Abstract][Full Text] [Related]
10. Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trial.
Chlebowski RT; Barrington W; Aragaki AK; Manson JE; Sarto G; OʼSullivan MJ; Wu D; Cauley JA; Qi L; Wallace RL; Prentice RL
Menopause; 2017 Feb; 24(2):133-141. PubMed ID: 27749739
[TBL] [Abstract][Full Text] [Related]
11. Sex hormone levels and risk of breast cancer with estrogen plus progestin.
Farhat GN; Parimi N; Chlebowski RT; Manson JE; Anderson G; Huang AJ; Vittinghoff E; Lee JS; Lacroix AZ; Cauley JA; Jackson R; Grady D; Lane DS; Phillips L; Simon MS; Cummings SR
J Natl Cancer Inst; 2013 Oct; 105(19):1496-503. PubMed ID: 24041978
[TBL] [Abstract][Full Text] [Related]
12. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.
Tang JY; Spaunhurst KM; Chlebowski RT; Wactawski-Wende J; Keiser E; Thomas F; Anderson ML; Zeitouni NC; Larson JC; Stefanick ML
J Natl Cancer Inst; 2011 Oct; 103(19):1469-75. PubMed ID: 21878677
[TBL] [Abstract][Full Text] [Related]
13. Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.
Chlebowski RT; Anderson GL; Sarto GE; Haque R; Runowicz CD; Aragaki AK; Thomson CA; Howard BV; Wactawski-Wende J; Chen C; Rohan TE; Simon MS; Reed SD; Manson JE
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26668177
[TBL] [Abstract][Full Text] [Related]
14. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.
Dignam JJ; Wieand K; Johnson KA; Raich P; Anderson SJ; Somkin C; Wickerham DL
Breast Cancer Res Treat; 2006 Jun; 97(3):245-54. PubMed ID: 16331345
[TBL] [Abstract][Full Text] [Related]
15. Exogenous Hormone Use and Endometrial Cancer in U.S. Black Women.
Sponholtz TR; Palmer JR; Rosenberg LA; Hatch EE; Adams-Campbell LL; Wise LA
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):558-565. PubMed ID: 29475971
[No Abstract] [Full Text] [Related]
16. Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
Beral V; Reeves G; Bull D; Green J;
J Natl Cancer Inst; 2011 Feb; 103(4):296-305. PubMed ID: 21278356
[TBL] [Abstract][Full Text] [Related]
17. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
[TBL] [Abstract][Full Text] [Related]
18. Estrogen plus progestin and risk of benign proliferative breast disease.
Rohan TE; Negassa A; Chlebowski RT; Lasser NL; McTiernan A; Schenken RS; Ginsberg M; Wassertheil-Smoller S; Page DL
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2337-43. PubMed ID: 18725513
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
20. The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context.
Chlebowski RT; Aragaki AK
Menopause; 2023 Apr; 30(4):454-461. PubMed ID: 36727752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
